A computational analysis of the structural determinants of APOBEC3's catalytic activity and vulnerability to HIV-1 Vif
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
UMass Chan Affiliations
Department of Biochemistry and Molecular PharmacologyDocument Type
Journal ArticlePublication Date
2014-12-01Keywords
Amino Acid SequenceCytosine Deaminase
Gene Expression Regulation
Humans
Membrane Potentials
Protein Binding
Protein Conformation
Protein Structure, Tertiary
Sequence Alignment
Static Electricity
vif Gene Products, Human Immunodeficiency Virus
Biochemistry
Structural Biology
Virology
Metadata
Show full item recordAbstract
APOBEC3s (A3) are Zn(2+) dependent cytidine deaminases with diverse biological functions and implications for cancer and immunity. Four of the seven human A3s restrict HIV by 'hypermutating' the reverse-transcribed viral genomic DNA. HIV Virion Infectivity Factor (Vif) counters this restriction by targeting A3s to proteasomal degradation. However, there is no apparent correlation between catalytic activity, Vif binding, and sequence similarity between A3 domains. Our comparative structural analysis reveals features required for binding Vif and features influencing polynucleotide deaminase activity in A3 proteins. All Vif-binding A3s share a negatively charged surface region that includes residues previously implicated in binding the highly-positively charged Vif. Additionally, catalytically active A3s share a positively charged groove near the Zn(2+) coordinating active site, which may accommodate the negatively charged polynucleotide substrate. Our findings suggest surface electrostatics, as well as the spatial extent of substrate accommodating region, are critical determinants of substrate and Vif binding across A3 proteins with implications for anti-retroviral and anti-cancer therapeutic design.Source
Virology. 2014 Dec;471-473:105-16. doi: 10.1016/j.virol.2014.09.023. Epub 2014 Oct 29. Link to article on publisher's siteDOI
10.1016/j.virol.2014.09.023Permanent Link to this Item
http://hdl.handle.net/20.500.14038/30366PubMed ID
25461536Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1016/j.virol.2014.09.023